DSM Sinochem Hosts Dialogue on Antimicrobial Resistance RoadmapBy
Part of the special news roundup of DCAT member companies for the DCAT Week ’17 Special Edition of DCAT Value Chain Insights (April 5, 2017)
DSM Sinochem Pharmaceuticals (DSP), a producer of sustainable antibiotics, next-generation statins, and anti-fungals, hosted an industry event for a dialogue on antimicrobial resistance (AMR) during DCAT Week 2017 held in New York from March 20-23, 2017.
DSP invited the signatory companies of the Industry Roadmap for Progress on Combatting Antimicrobial Resistance, which was a document signed during the United Nations (UN) General Assembly in September 2016, to discuss the implementation of the Roadmap. The Roadmap lays out commitments from 13 pharmaceutical and generics companies to combat AMR in the following four areas:
- Reduce the environmental impact from the production of antibiotics
- Help ensure antibiotics are used only by patients who need them
- Improve access to current and future antibiotics, vaccines, and diagnostics
- Explore new opportunities for open collaborations between industry and the public sector
The 13 pharmaceutical and generics companies that signed the Roadmap include Allergan, AstraZeneca, Cipla, DSM Sinochem Pharmaceuticals, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Novartis, Pfizer, Roche, Sanofi, Shionogi, and Wockhardt.
The keynote speaker included in DSP’s event was H.E. Ambassador Jose Gomez-Camacho, Permanent Representative of Mexico to the United Nations. Ambassador Gomez-Camacho facilitated consultations and the setup of the Political Declaration of the High-Level Meeting of the UN General Assembly on AMR, as adopted on September 2016. Additional keynotes were given by Jayasree Iyer, executive director, Access to Medicine Foundation, Steve Brooks, vice president EHS, Pfizer, Ramanan Laxminarayan, director of the Center for Disease Dynamics, Economics & Policy, and Dr. Nata Menabde, executive director of the World Health Organization Office at the UN. The keynotes speakers shared their views on dealing with AMR, the role of the pharmaceutical industry to foster discussions between the participants, strengthening efforts against AMR, and implementing the Roadmap.
Source: DSM Sinochem Pharmaceuticals and International Federation of Pharmaceutical Manufacturers & Associations